NDC 29033-0003-01
SUCRALFATE 1GM TAB 100
Available — 2-Day Shipping
NDC
29033-0003-01
Generic Name
—
Brand Name
—
Strength
—
Dosage Form
—
Route
—
Package Size
—
Labeler
—
FDA Drug Information
Indications & Usage
INDICATIONS AND USAGE Sucralfate tablets are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.
Source: FDA. For professional use only. Not a substitute for prescribing information.
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 29033-0003-01 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).